|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Ranbaxy_Laboratories
|
|
gptkbp:CEO
|
gptkb:Dilip_Shanghvi
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:foundedBy
|
gptkb:Dilip_Shanghvi
|
|
gptkbp:foundedYear
|
1983
|
|
gptkbp:fullName
|
gptkb:Sun_Pharmaceutical_Industries_Limited
|
|
gptkbp:headquartersLocation
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
SUNPHARMA
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE044A01036
|
|
gptkbp:market
|
Global
|
|
gptkbp:netIncome
|
INR 85.8 billion (FY 2023)
|
|
gptkbp:notableProduct
|
gptkb:Absorica
gptkb:BromSite
gptkb:Ilumya
gptkb:Odomzo
|
|
gptkbp:numberOfEmployees
|
over 37,000
|
|
gptkbp:parentCompany
|
gptkb:Sun_Pharmaceutical_Industries_Limited
|
|
gptkbp:products
|
Active pharmaceutical ingredients
Generic drugs
Specialty medicines
|
|
gptkbp:revenue
|
INR 432.5 billion (FY 2023)
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:SUNPHARMA
|
|
gptkbp:subsidiary
|
gptkb:Sun_Pharma_Advanced_Research_Company
gptkb:Taro_Pharmaceutical_Industries
|
|
gptkbp:website
|
https://www.sunpharma.com/
|
|
gptkbp:bfsParent
|
gptkb:Sun_Pharma
gptkb:Sun_Pharmaceutical_Industries
|
|
gptkbp:bfsLayer
|
6
|